Financials EastWest Bioscience Inc.

Equities

EAST.H

CA27783V1076

Other Specialty Retailers

Delayed Toronto S.E. 09:54:31 28/04/2023 am IST 5-day change 1st Jan Change
0.025 CAD -.--% Intraday chart for EastWest Bioscience Inc. -.--% -.--%

Valuation

Fiscal Period: July 2018 2019 2020 2021
Capitalization 1 13.52 4.486 3.241 1.951
Enterprise Value (EV) 1 13.69 6.367 5.403 3.313
P/E ratio -2.89 x -1.19 x -2.59 x -1.18 x
Yield - - - -
Capitalization / Revenue 104 x 3.23 x 3.51 x 1.89 x
EV / Revenue 106 x 4.58 x 5.85 x 3.2 x
EV / EBITDA -7.94 x -2.43 x -4.23 x -2.01 x
EV / FCF -41,78,476 x -57,42,003 x -1,23,04,877 x -1,60,77,707 x
FCF Yield -0% -0% -0% -0%
Price to Book 5.1 x 7.48 x -71 x -4.44 x
Nbr of stocks (in thousands) 75,118 81,562 92,606 97,569
Reference price 2 0.1800 0.0550 0.0350 0.0200
Announcement Date 28/11/18 29/01/20 29/12/20 03/12/21
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: July 2016 2017 2018 2019 2020 2021
Net sales 1 0.001137 0.024 0.1294 1.39 0.9228 1.034
EBITDA 1 -0.3502 -0.5644 -1.724 -2.622 -1.277 -1.647
EBIT 1 -0.3504 -0.5769 -1.827 -2.758 -1.403 -1.765
Operating Margin -30,815.13% -2,404.01% -1,411.58% -198.39% -152.08% -170.69%
Earnings before Tax (EBT) 1 -0.3683 -0.8403 -3.286 -3.649 -1.132 -1.628
Net income 1 -0.3683 -0.8403 -3.286 -3.649 -1.132 -1.605
Net margin -32,390.5% -3,501.9% -2,538.98% -262.49% -122.68% -155.24%
EPS 2 -0.0252 -0.0260 -0.0623 -0.0461 -0.0135 -0.0169
Free Cash Flow - -0.1879 -3.277 -1.109 -0.4391 -0.206
FCF margin - -783.24% -2,531.48% -79.77% -47.58% -19.92%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 31/07/17 28/11/17 28/11/18 29/01/20 29/12/20 03/12/21
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: Juli 2016 2017 2018 2019 2020 2021
Net Debt 1 - 0.07 0.17 1.88 2.16 1.36
Net Cash position 1 0.07 - - - - -
Leverage (Debt/EBITDA) - -0.1204 x -0.0987 x -0.7175 x -1.693 x -0.8267 x
Free Cash Flow - -0.19 -3.28 -1.11 -0.44 -0.21
ROE (net income / shareholders' equity) -447% -1,653% -255% -224% -409% 2,890%
ROA (Net income/ Total Assets) - -135% -49.6% -42.4% -25.2% -32%
Assets 1 - 0.6219 6.626 8.606 4.486 5.025
Book Value Per Share 2 0.0100 -0 0.0400 0.0100 -0 -0
Cash Flow per Share 2 0 0 0.0200 0 0 0.0100
Capex 1 0 0.09 1.69 0.03 0 0.01
Capex / Sales 72.74% 372.83% 1,307.07% 1.96% 0.14% 0.91%
Announcement Date 31/07/17 28/11/17 28/11/18 29/01/20 29/12/20 03/12/21
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. EAST.H Stock
  4. Financials EastWest Bioscience Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW